At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference.
Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact.
We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together.
Job Description
This role leads a team within Portfolio Strategy & Analytics (PS&A) at Gilead, with accountability for PS&A support across all assets and therapeutic areas. This role ensures consistent, high‑quality strategic, analytical, and decision support across the portfolio. This leader will develop and lead a team that partners closely with Gilead Asset Teams (GATs) and Development & Evidence Teams (DETs), while serving as a senior strategic partner to multiple groups and leaders across the company, including the Team System Office, Global Project Management, and Therapeutic Area (TA) Heads to align portfolio processes, tools, platforms, and ways of working.
This role will be accountable for PS&A‑led enterprise processes that directly enable teams, including lifecycle planning and options development and evaluation, ensuring consistent standards, and capability building across the organization. This leader will play a key role on the PS&A leadership team and report to the VP of PS&A.
This is a site base role at our global headquarters in Foster City, CA.
Responsibilities
Lead and manage a PS&A team, supporting assets across the enterprise portfolio
Recruit, develop, and retain high‑performing talent
Build strong analytical, partnership, and influence capabilities across the team
Guide leaders and teams in framing options, risks, trade‑offs, and decision points aligned with enterprise strategy
Ensure consistent, high‑quality analytics, planning, and decision support for GATs and DETs
Ensure timely delivery of recurring and ad hoc insights to leadership and governance forums
Oversee asset‑level PS&A analyses within broader portfolio context to support strategic decisions
Partner with the organizations such as the Team System Office and Global Project Management to align on portfolio processes and team deliverables
Act as a senior thought partner to cross‑functional leaders on portfolio and asset‑level decisions. Drive continuous improvement in partnership with enterprise stakeholders
Own PS&A enterprise development and roll-out of PS&A processes, including lifecycle planning and options development and evaluation
Sponsor initiatives to evolve PS&A team support methodologies, systems, tools, and analytics platforms
Drive knowledge sharing, best‑practice development, and capability building across PS&A and partners
Requirements
MA/MS/MBA or PhD with 14+ years of relevant experience in life sciences, or BA/BS with 16+ years of relevant experience
5+ years of strategic portfolio analysis and insights experience
Extensive experience leading complex, cross‑functional and enterprise‑level initiatives
Experience building and leading processes and change management with complex teams
Strong track record delivering analyses that inform portfolio‑wide and asset‑level decisions
Deep expertise in biopharma portfolio strategy
Demonstrated ability to influence senior leaders across functions, assets, and governance forums
Strong executive presence with experience leading enterprise processes and change initiatives
For additional benefits information, visit:
https://www.gilead.com/careers/compensation-benefits-and-wellbeing
* Eligible employees may participate in benefit plans, subject to the terms and conditions of the applicable plans.
Gilead Sciences Inc. is committed to providing equal employment opportunities to all employees and applicants for employment, and is dedicated to fostering an inclusive work environment comprised of diverse perspectives, backgrounds, and experiences. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, sex, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact ApplicantAccommodations@gilead.com for assistance.
For more information about equal employment opportunity protections, please view the 'Know Your Rights' poster.
NOTICE: EMPLOYEE POLYGRAPH PROTECTION ACT
YOUR RIGHTS UNDER THE FAMILY AND MEDICAL LEAVE ACT
Gilead Sciences will not discharge or in any other manner discriminate against employees or applicants because they have inquired about, discussed, or disclosed their own pay or the pay of another employee or applicant. However, employees who have access to the compensation information of other employees or applicants as a part of their essential job functions cannot disclose the pay of other employees or applicants to individuals who do not otherwise have access to compensation information, unless the disclosure is (a) in response to a formal complaint or charge, (b) in f